John Sweetenham, MD, PhD

Editorials by John Sweetenham, MD


Response-adapted therapy of lymphoma: Real progress or really confusing?

HemOnc Today, August 10, 2014
John Sweetenham, MD
In the past few years, the lymphoma literature has featured an increasing number of studies — some well-designed, most not so — designed…
EditorialPublication Exclusive

Better cancer care: My ‘one thing’ to learn more about this week

HemOnc Today, April 10, 2015
John Sweetenham, MD
In the past few weeks, I have been fortunate enough to be involved in several strategic retreats. These retreats have involved different groups of…